LGC makes “next logical step” and brings lab services to Russia

By Nick Taylor

- Last updated on GMT

Related tags Russia Marketing

LGC Standards has made the “next logical step” in its “concerted effort” to expand internationally by opening an office in St Petersburg, Russia, less than six months after it moved into China.

Speaking to Outsourcing-Pharma Amanda Russell, marketing manager at LGC Standards, explained how the company was attracted to the growth of the Russian pharma market, which Espicom predicts is 17 per cent per annum.

Growth of the pharma industry has had the knock on effect of increasing laboratory work and, with companies in Russia aiming to meet western standards, LGC believes there is demand for its products and services.

Russell added that this belief is underpinned by LGC’s experience at its Poland-based office, which also served the Russian market. LGC often begins serving a country from a neighbouring territory, according to Russell, and establishes another office when demand increases.

This process has now moved LGC into Russia. Russell explained that although the Polish office houses Russian-speaking experts, clients prefer LGC to have a base in their home country and the expansion provides this.

From this office LGC will support laboratories in the areas of reference material distribution, proficiency testing, production of pharma impurities and custom synthesis.

Significant expansions

Since taking its current form in 2007 LGC has established offices or sent sales representatives to numerous countries but Russell believes the expansions into China and Russia are the most significant.

These expansions have both occurred in a busy six month period for LGC and the company is looking at setting up more offices, according to Russell.

Although she was unable to name locations Russell confirmed that LGC is in talks with its existing offices and representatives about further expansions.

In addition to Russia and China LGC has a presence, either office or sales representative, in countries throughout Western and Eastern Europe, as well as the US and India.

Related news

Related products

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Content provided by Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us


View more